Gene editing technology is the behavior of artificially modifying or changing the gene sequence of host cells, and its practical application and development have brought many ethical risks to human society. In order to ensure the healthy and orderly development of gene editing technology, we should take a cautious and responsible attitude towards its practical application and pay attention to its risk prevention. In the aspect of ethical risk management, we should distinguish different types of gene editing behavior and establish a classified management mechanism. Gene therapy should generally be allowed. For gene enhancement, the pursuit of special endowment should be strictly prohibited. The behavior of gene editing in germ line should be resisted in principle and allowed only when exceptions are made.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: